Table 3.
Sex differential effect on COVID-19 survival time between different age and wards using Cox regression
| Ward | Age Group | Sex | HR (95% CI) | p-Value | |
|---|---|---|---|---|---|
| Wards | ICU.CCU | ||||
| Children (0–14) | Male vs. Female | 0.67 (0.13–3.34) | 0.620 | ||
| Youth (15–24) | Male vs. Female | 0.46 (0.12–1.76) | 0.258 | ||
| Adults (25–64) | Male vs. Female | 1.24 (1.00–1.55) | 0.051 | ||
| Seniors (>65) | Male vs. Female | 1.25 (1.06–1.48) | 0.009 | ||
| Others | |||||
| Children (0–14) | Male vs. Female | 1.40 (0.47–4.17) | 0.541 | ||
| Youth (15–24) | Male vs. Female | 1.04 (0.43–2.51) | 0.935 | ||
| Adults (25–64) | Male vs. Female | 1.27 (1.09–1.48) | 0.003 | ||
| Seniors (>65) | Male vs. Female | 1.25 (1.12–1.39) | <0.001 | ||
| COVID-19 status | Negative | ||||
| Children (0–14) | Male vs. Female | – - | – - | ||
| Youth (15–24) | Male vs. Female | 0.23 (0.02–2.57) | 0.234 | ||
| Adults (25–64) | Male vs. Female | 1.22 (0.82–1.80) | 0.323 | ||
| Seniors (>65) | Male vs. Female | 1.21 (0.93–1.57) | 0.152 | ||
| Positive | |||||
| Children (0–14) | Male vs. Female | 0.18 (0.02–1.71) | 0.135 | ||
| Youth (15–24) | Male vs. Female | 1.15 (0.43–3.08) | 0.774 | ||
| Adults (25–64) | Male vs. Female | 1.34 (1.14–1.58) | 0.001 | ||
| Seniors (>65) | Male vs. Female | 1.23 (1.09–1.39) | 0.001 | ||
| Suspected | |||||
| Children (0–14) | Male vs. Female | 1.53 (0.49–4.84) | 0.466 | ||
| Youth (15–24) | Male vs. Female | 1.11 (0.33–3.80) | 0.865 | ||
| Adults (25–64) | Male vs. Female | 1.26 (1.00–1.59) | 0.046 | ||
| Seniors (>65) | Male vs. Female | 1.22 (1.03–1.44) | 0.021 | ||
| Total | |||||
| Children (0–14) | Male vs. Female | 1.05 (0.43–2.55) | 0.917 | ||
| Youth (15–24) | Male vs. Female | 0.96 (0.47–1.97) | 0.911 | ||
| Adults (25–64) | Male vs. Female | 1.28 (1.13–1.46) | 0.000 | ||
| Seniors (>65) | Male vs. Female | 1.27 (1.15–1.39) | 0.000 |